Karpus Investment Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-603,425
Closed -$6.37M – 252
2026
Q1
$6.37M Sell
603,425
-10,000
-2% -$105K 0.2% 115
2025
Q4
$6.42M Sell
613,425
-3,350
-0.5% -$34.9K 0.2% 114
2025
Q3
$6.38M Hold
616,775
– – 0.2% 97
2025
Q2
$6.33M Buy
616,775
+9,850
+2% +$100K 0.2% 107
2025
Q1
$6.12M Buy
+606,925
New +$6.1M 0.2% 114

Other funds holding TDAC

Karpus Investment Management's TDAC Position: Q2 2026 in Review

Karpus Investment Management sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 603,425 shares — an estimated $6.37M sold.

Karpus Investment Management first reported a position in TDAC in Q1 2025 and held it in 5 quarters. The position peaked at $6.42M in Q4 2025. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Karpus Investment Management reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Karpus Investment Management sold 603,425 Translational Development Acquisition Corp shares in Q2 2026, an estimated $6.37M.
  • Karpus Investment Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 5 quarters.
  • Karpus Investment Management's Translational Development Acquisition Corp position peaked at $6.42M in Q4 2025.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Karpus Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.